FDA Issues Final Guidance on Reprocessing of Reusable Medical Devices

By MedTech Intelligence Staff

The U.S. Food and Drug Administration (FDA) announced new actions to enhance the safety of reusable medical devices and address the possible spread of infectious agents between uses. The new

The U.S. Food and Drug Administration (FDA) announced new actions to enhance the safety of reusable medical devices and address the possible spread of infectious agents between uses. The new

Continue reading

Engage Early to Get Product to Market on Time

…or needed additional engineering support. We were working together as one team.” For more information on UL’s services to support certification and global regulatory approvals, email Medical.Inquiry@ul.com or visit www.ul.com/medical….

…or needed additional engineering support. We were working together as one team.” For more information on UL’s services to support certification and global regulatory approvals, email Medical.Inquiry@ul.com or visit www.ul.com/medical….

Continue reading

Medical Device Joint Ventures and Acquisitions in Asia

By Ames Gross

An increasing number of Western device companies have been acquiring or entering into joint ventures with Asian medical firms. Acquisitions and joint ventures with Asian medical companies can provide many…

An increasing number of Western device companies have been acquiring or entering into joint ventures with Asian medical firms. Acquisitions and joint ventures with Asian medical companies can provide many…

Continue reading

Reimbursement Report

Living with a Legacy – Reimbursement Barriers Based on Technologies that Came Before

By Elizabeth Brown, MD

…by their trade names instead of considering them collectively as a commodity. Additionally payers have imposed a very high evidence requirement consisting of randomized trials comparing the allografts either to…

…by their trade names instead of considering them collectively as a commodity. Additionally payers have imposed a very high evidence requirement consisting of randomized trials comparing the allografts either to…

Continue reading

Dr. Christopher Joseph Devine, President, Devine Guidance International
Devine Guidance

Refusing an FDA Request Will Always End Badly!

By Dr. Christopher Joseph Devine

…invaluable in a device establishment’s quest for commercialization of a new medical device. For example, if a device manufacturer is confident that their product is going to be a Class…

…invaluable in a device establishment’s quest for commercialization of a new medical device. For example, if a device manufacturer is confident that their product is going to be a Class…

Continue reading

Are You Ready for 3-D Printing?

…industries and product categories. The authors advise companies to build a group of executive champions within the engineering, quality, operations, and procurement units. Some medical-device companies, for example, already have…

…industries and product categories. The authors advise companies to build a group of executive champions within the engineering, quality, operations, and procurement units. Some medical-device companies, for example, already have…

Continue reading

Dr. Christopher Joseph Devine, President, Devine Guidance International
Devine Guidance

Receiving Inspection – Not Much Value; However…

By Dr. Christopher Joseph Devine

…managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA’s enforcement page. (2015, February). FDA.gov Website. Retrieved March1, 2015, from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm433248.htm….

…managing key attributes of a FDA-compliant quality management system – 21 CFR, Part 820 Compliance. Charleston, SC: Amazon. FDA’s enforcement page. (2015, February). FDA.gov Website. Retrieved March1, 2015, from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm433248.htm….

Continue reading

Using Root Cause Analysis for Powerful Defect Prevention

…whether the action corrected the underlying problem partially, completely, or not at all. For example, if a software development team is repeatedly discovering defects after their application is released to…

…whether the action corrected the underlying problem partially, completely, or not at all. For example, if a software development team is repeatedly discovering defects after their application is released to…

Continue reading

Johnson & Johnson to Sell Cordis to Cardinal Health for $1.94 billion.

…evenly between cardiology and endovascular products,” with about 70 percent coming from outside the U.S., according to a press release. Cardinal CEO George Barrett said the company may make more…

…evenly between cardiology and endovascular products,” with about 70 percent coming from outside the U.S., according to a press release. Cardinal CEO George Barrett said the company may make more…

Continue reading

Aidan Petrie, Chief Innovation Officer and Co-Founder, Ximedica
MEDdesign

Driving Change in MedTech – Taking Notes from Uber

By Aidan Petrie

…savvy entrepreneurs in the medical field ought to take notice of. Take the ride-sharing service Uber, for example. This company has taken the struggling, often unloved taxi industry and reinvented…

…savvy entrepreneurs in the medical field ought to take notice of. Take the ride-sharing service Uber, for example. This company has taken the struggling, often unloved taxi industry and reinvented…

Continue reading